Clinical Trial Update: TO ASSESS THE EFFICACY AND SAFETY OF PF-06650833, PF-06651600, AND TOFACITINIB ALONE AND IN COMBINATION IN PARTICIPANTS WITH ACTIVE RHEUMATOID ARTHRITIS WITH AN INADEQUATE RESPONSE TO METHOTREXATE [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating PF-06650833, PF-06651600, and tofacitinib alone and in combination in rheumatoid arthritis patients with inadequate met…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• PF-06650833 (PF-06650833)
• PF-06651600 (PF-06651600)
• Tofacitinib (tofacitinib)

Snippet

Sponsor: Pfizer | Conditions: Rheumatoid Arthritis | Phase 2 | Status: COMPLETED | Results posted: 2023-04-07